![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Gruberg L. Waksman R.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.10, Iss.5, 2001-05, pp. : 891-907
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Role of drugs in prevention of coronary restenosis
Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty
By Hamon M.
Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sirolimus-eluting stent superior for coronary artery restenosis prevention
Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. :